Synapse

← BMC Clinical Pharmacology

Papers in BMC Clinical Pharmacology

Page 2 · newest first

  1. Fatal drug poisonings in a Swedish general populationBMC Clinical Pharmacology · 2009
  2. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk peopleBMC Clinical Pharmacology · 2009
  3. Methanol poisoning and long term sequelae – a six years follow-up after a large methanol outbreakBMC Clinical Pharmacology · 2009
  4. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDsBMC Clinical Pharmacology · 2009
  5. Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case seriesBMC Clinical Pharmacology · 2009
  6. A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled studyBMC Clinical Pharmacology · 2009
  7. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibioticsBMC Clinical Pharmacology · 2009
  8. Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitoninBMC Clinical Pharmacology · 2008
  9. Systematic review of dexketoprofen in acute and chronic painBMC Clinical Pharmacology · 2008
  10. Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover studyBMC Clinical Pharmacology · 2008
  11. Long-term platinum retention after treatment with cisplatin and oxaliplatinBMC Clinical Pharmacology · 2008
  12. Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertensionBMC Clinical Pharmacology · 2008
  13. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon CalcitoninBMC Clinical Pharmacology · 2008
  14. Evaluation of safe and effective administration of nitrous oxide after a postgraduate training courseBMC Clinical Pharmacology · 2008
  15. Individual case safety reports in children in commonly used drug groups – signal detectionBMC Clinical Pharmacology · 2008
  16. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database studyBMC Clinical Pharmacology · 2007
  17. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3BBMC Clinical Pharmacology · 2007
  18. Pharmacokinetics of recombinant human growth hormone administered by cool.click™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needleBMC Clinical Pharmacology · 2007
  19. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clinical Pharmacology · 2007
  20. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective studyBMC Clinical Pharmacology · 2007
  21. Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individualsBMC Clinical Pharmacology · 2007
  22. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controlsBMC Clinical Pharmacology · 2007
  23. Does atenolol differ from other β-adrenergic blockers?BMC Clinical Pharmacology · 2007
  24. Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphoneBMC Clinical Pharmacology · 2007
  25. Heterogeneity of human adipose blood flowBMC Clinical Pharmacology · 2007
  26. Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay)BMC Clinical Pharmacology · 2006
  27. Finasteride induced depression: a prospective studyBMC Clinical Pharmacology · 2006
  28. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapyBMC Clinical Pharmacology · 2006
  29. Hemolytic uremic syndrome following the infusion of oxaliplatin: case reportBMC Clinical Pharmacology · 2006
  30. Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteersBMC Clinical Pharmacology · 2006
  31. Serum sickness-like reaction associated with cefazolinBMC Clinical Pharmacology · 2006
  32. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilatBMC Clinical Pharmacology · 2006
  33. Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosaBMC Clinical Pharmacology · 2005
  34. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)BMC Clinical Pharmacology · 2005
  35. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai womenBMC Clinical Pharmacology · 2005
  36. Hospital use of systemic antifungal drugsBMC Clinical Pharmacology · 2005
  37. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational studyBMC Clinical Pharmacology · 2004
  38. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case reportBMC Clinical Pharmacology · 2004